Cytosorbents
CTSO
#11199
Rank
A$1.54 M
Marketcap
A$0.49
Share price
0.03%
Change (1 day)
-64.29%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -A$18.07 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$37.2 Million. In 2025 the company made an earning of -A$12.07 Million, an increase over its 2024 earnings that were of -A$31.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$18.07 Million49.7%
2025 -A$12.07 Million-62.16%
2024 -A$31.88 Million-22.49%
2023 -A$41.14 Million-13.52%
2022 -A$47.57 Million34.04%
2021 -A$35.49 Million182.17%
2020 -A$12.58 Million-55.97%
2019 -A$28.56 Million14.17%
2018 -A$25.02 Million95.14%
2017 -A$12.82 Million-22.32%
2016 -A$16.51 Million39.1%
2015 -A$11.87 Million-12.89%
2014 -A$13.62 Million89%
2013 -A$7.21 Million26.65%
2012 -A$5.69 Million-26.02%
2011 -A$7.69 Million-288.45%
2010 A$4.08 M-4.17%
2009 A$4.25 M-287.19%
2008 -A$2.28 Million-47.12%
2007 -A$4.31 Million41.78%
2006 -A$3.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.24 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.09 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
A$77.86 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA